Details of the Drug

General Information of Drug (ID: DMPFJOP)

• Drug Name: US-APR2020

Indication

Disease Entry	ICD 11	Status	REF
Chronic kidney disease	GB61	Phase 2/3	[1]

• Drug Type: Live biotherapeutic
• Cross-matching ID: TTD ID: D3YKX2

References

• [1] ClinicalTrials.gov (NCT05407389) An Open-Label Rollover Extension Phase 2 Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study. U.S.National Institutes of Health.